Translation deregulation in B-cell lymphomas

Biochemical Society Transactions

Volumn 38, Issue 6, 2010, Pages 1593-1597

  Horvilleur, Emilie ^a   Wilson, Lindsay A ^a   Willis, Anne E ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

B cell lymphoma; Cancer; Immunoglobulin gene rearrangement; Internal ribosomal entry segment (IRES); MicroRNA (miRNA); Transcription factor

Indexed keywords

MICRORNA;

3' UNTRANSLATED REGION; B CELL LYMPHOMA; B LYMPHOCYTE; CANCER GROWTH; CELL MATURATION; CONFERENCE PAPER; LARGE CELL LYMPHOMA; LYMPHOCYTE DIFFERENTIATION; NONHUMAN; ONTOGENY; PRIORITY JOURNAL; PROGNOSIS; SOMATIC MUTATION; TRANSLATION REGULATION;

B-LYMPHOCYTES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHOMA, B-CELL; MICRORNAS; PROGNOSIS; PROTEIN BIOSYNTHESIS;

EID: 78649758054     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST0381593     Document Type: Conference Paper

References (43)

1. Quinn, M., Babb, P., Brock, A., Kirby, L. and Jones, J. (2001) Cancer Trends in England and Wales 1950-1999: Studies on Medical and Population Subjects No. 66, Office for National Statistics, London
2. Klein, U. and Dalla-Favera, R. (2008) Germinal centres: role in B-cell physiology and malignancy. Nat. Rev. Immunol. 8, 22-33
3. Filipowicz, W., Bhattacharyya, S.N. and Sonenberg, N. (2008) Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat. Rev. Genet. 9, 102-114
4. O'Carroll, D., Mecklenbrauker, I., Das, P.P., Santana, A., Koenig, U., Enright, A.J., Miska, E.A. and Tarakhovsky, A. (2007) A Slicer-independent role for Argonaute 2 in hematopoiesis and the microRNA pathway. Genes Dev. 21, 1999-2004
5. Koralov, S.B., Muljo, S.A., Galler, G.R., Krek, A., Chakraborty, T., Kanellopoulou, C., Jensen, K., Cobb, B.S., Merkenschlager, M., Rajewsky, N. and Rajewsky, K. (2008) Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage. Cell 132, 860-874
6. Chen, C.Z., Li, L., Lodish, H.F. and Bartel, D.P. (2004) MicroRNAs modulate hematopoietic lineage differentiation. Science 303, 83-86
7. Malumbres, R., Sarosiek, K.A., Cubedo, E., Ruiz, J.W., Jiang, X., Gascoyne, R.D., Tibshirani, R. and Lossos, I.S. (2009) Differentiation stage-specific expression of microRNAs in B lymphocytes and diffuse large B-cell lymphomas. Blood 113, 3754-3764
8. Zhang, J., Jima, D.D., Jacobs, C., Fischer, R., Gottwein, E., Huang, G., Lugar, P.L., Lagoo, A.S., Rizzieri, D.A., Friedman, D.R. et al. (2009) Patterns of microRNA expression characterize stages of human B-cell differentiation. Blood 113, 4586-4594
9. Lawrie, C.H., Chi, J., Taylor, S., Tramonti, D., Ballabio, E., Palazzo, S., Saunders, N.J., Pezzella, F., Boultwood, J., Wainscoat, J.S. and Hatton, C.S. (2009) Expression of microRNAs in diffuse large B cell lymphoma is associated with immunophenotype, survival and transformation from follicular lymphoma. J. Cell. Mol. Med. 13, 1248-1260
10. Felli, N., Fontana, L., Pelosi, E., Botta, R., Bonci, D., Facchiano, F., Liuzzi, F., Lulli, V., Morsilli, O., Santoro, S. et al. (2005) MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation. Proc. Natl. Acad. Sci. U.S.A. 102, 18081-18086
11. Li, C., Kim, S.W., Rai, D., Bolla, A.R., Adhvaryu, S., Kinney, M.C., Robetorye, R.S. and Aguiar, R.C. (2009) Copy number abnormalities, MYC activity, and the genetic fingerprint of normal B cells mechanistically define the microRNA profile of diffuse large B-cell lymphoma. Blood 113, 6681-6690
12. Ioannidis, J.P., Allison, D.B., Ball, C.A., Coulibaly, I., Cui, X., Culhane, A.C., Falchi, M., Furlanello, C., Game, L., Jurman, G. et al. (2009) Repeatability of published microarray gene expression analyses. Nat. Genet. 41, 149-155
13. Navarro, A., Gaya, A., Martinez, A., Urbano-Ispizua, A., Pons, A., Balagué, O., Gel, B., Abrisqueta, P., Lopez-Guillermo, A., Artells, R. et al. (2008) MicroRNA expression profiling in classic Hodgkin lymphoma. Blood 111, 2825-2832
14. Zhao, J.J., Lin, J., Lwin, T., Yang, H., Guo, J., Kong, W., Dessureault, S., Moscinski, L.C., Rezania, D., Dalton, W.S. et al. (2010) microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma. Blood 115, 2630-2639
15. Leucci, E., Cocco, M., Onnis, A., De Falco, G., van Cleef, P., Bellan, C., van Rijk, A., Nyagol, J., Byakika, B., Lazzi, S. et al. (2008) MYC translocation-negative classical Burkitt lymphoma cases: an alternative pathogenetic mechanism involving miRNA deregulation. J. Pathol. 216, 440-450
16. Kluiver, J., Haralambieva, E., de Jong, D., Blokzijl, T., Jacobs, S., Kroesen, B.J., Poppema, S. and Van Den Berg, A. (2006) Lack of BIC and microRNA miR-155 expression in primary cases of Burkitt lymphoma. Genes Chromosomes Cancer 45, 147-153
17. Eis, P.S., Tam, W., Sun, L., Chadburn, A., Li, Z., Gomez, M.F., Lund, E. and Dahlberg, J.E. (2005) Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc. Natl. Acad. Sci. U.S.A. 102, 3627-3632
18. Gironella, M., Seux, M., Xie, M.J., Cano, C., Tomasini, R., Gommeaux, J., Garcia, S., Nowak, J., Yeung, M.L., Jeang, K.T. et al. (2007) Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development. Proc. Natl. Acad. Sci. U.S.A. 104, 16170-16175
19. Teng, G., Hakimpour, P., Landgraf, P., Rice, A., Tuschl, T., Casellas, R. and Papavasiliou, F.N. (2008) MicroRNA-155 is a negative regulator of activation-induced cytidine deaminase. Immunity 28, 621-629
20. Sampson, V.B., Rong, N.H., Han, J., Yang, Q., Aris, V., Soteropoulos, P., Petrelli, N.J., Dunn, S.P. and Krueger, L.J. (2007) MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells. Cancer Res. 67, 9762-9770
21. Chim, C.S., Wong, K.Y., Qi, Y., Loong, F., Lam, W.L., Wong, L.G., Jin, D.Y., Costello, J.F. and Liang, R. (2010) Epigenetic inactivation of the miR-34a in hematological malignancies. Carcinogenesis 31, 745-750
22. He, L., Thomson, J.M., Hemann, M.T., Hernando-Monge, E., Mu, D., Goodson, S., Powers, S., Cordon-Cardo, C., Lowe, S.W., Hannon, G.J. and Hammond, S.M. (2005) A microRNA polycistron as a potential human oncogene. Nature 435, 828-833
23. Calin, G.A., Dumitru, C.D., Shimizu, M., Bichi, R., Zupo, S., Noch, E., Aldler, H., Rattan, S., Keating, M., Rai, K. et al. (2002) Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. U.S.A. 99, 15524-15529
24. Wang, S., Rosenwald, I.B., Hutzler, M.J., Pihan, G.A., Savas, L., Chen, J.J. and Woda, B.A. (1999) Expression of the eukaryotic translation initiation factors 4E and 2α in non-Hodgkin's lymphomas. Am. J. Pathol. 155, 247-255
25. Rosenwald, I.B., Koifman, L., Savas, L., Chen, J.J., Woda, B.A. and Kadin, M.E. (2008) Expression of the translation initiation factors eIF-4E and eIF-2* is frequently increased in neoplastic cells of Hodgkin lymphoma. Hum. Pathol. 39, 910-916
26. Reinert, L.S., Shi, B., Nandi, S., Mazan-Mamczarz, K., Vitolo, M., Bachman, K.E., He, H. and Gartenhaus, R.B. (2006) MCT-1 protein interacts with the cap complex and modulates messenger RNA translational profiles. Cancer Res. 66, 8994-9001
27. Hay, N. and Sonenberg, N. (2004) Upstream and downstream of mTOR. Genes Dev. 18, 1926-1945
28. Muthukkumar, S., Ramesh, T.M. and Bondada, S. (1995) Rapamycin, a potent immunosuppressive drug, causes programmed cell death in B lymphoma cells. Transplantation 60, 264-270
29. Hipp, S., Ringshausen, I., Oelsner, M., Bogner, C., Peschel, C. and Decker, T. (2005) Inhibition of the mammalian target of rapamycin and the induction of cell cycle arrest in mantle cell lymphoma cells. Haematologica 90, 1433-1434
30. Wanner, K., Hipp, S., Oelsner, M., Ringshausen, I., Bogner, C., Peschel, C. and Decker, T. (2006) Mammalian target of rapamycin inhibition induces cell cycle arrest in diffuse large B cell lymphoma (DLBCL) cells and sensitises DLBCL cells to rituximab. Br. J. Haematol. 134, 475-484
31. Choo, A.Y., Yoon, S.O., Kim, S.G., Roux, P.P. and Blenis, J. (2008) Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation. Proc. Natl. Acad. Sci. U.S.A. 105, 17414-17419
32. Hsieh, A.C., Costa, M., Zollo, O., Davis, C., Feldman, M.E., Testa, J.R., Meyuhas, O., Shokat, K.M. and Ruggero, D. (2010) Genetic dissection of the oncogenic mTOR pathway reveals druggable addiction to translational control via 4EBP-eIF4E. Cancer Cell 17, 249-261
33. Hess, G., Herbrecht, R., Romaguera, J., Verhoef, G., Crump, M., Gisselbrecht, C., Laurell, A., Offner, F., Strahs, A., Berkenblit, A. et al. (2009) Phase III study to evaluate temsirolimus compared with investigator's choice therapy for the treatment of relapsed or refractory mantle cell lymphoma. J. Clin. Oncol. 27, 3822-3829
34. Ruggero, D., Montanaro, L., Ma, L., Xu, W., Londei, P., Cordon-Cardo, C. and Pandolfi, P.P. (2004) The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis. Nat. Med. 10, 484-486
35. Kim, S., Li, Q., Dang, C.V. and Lee, L.A. (2000) Induction of ribosomal genes and hepatocyte hypertrophy by adenovirus-mediated expression of c-Myc in vivo. Proc. Natl. Acad. Sci. U.S.A. 97, 11198-11202
36. Arabi, A., Wu, S., Ridderstråle, K., Bierhoff, H., Shiue, C., Fatyol, K., Fahlén, S., Hydbring, P., Söderberg, O., Grummt, I. et al. (2005) c-Myc associates with ribosomal DNA and activates RNA polymerase I transcription. Nat. Cell Biol. 7, 303-310
37. Barna, M., Pusic, A., Zollo, O., Costa, M., Kondrashov, N., Rego, E., Rao, P.H. and Ruggero, D. (2008) Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency. Nature 456, 971-975
38. Chang, T.C., Yu, D., Lee, Y.S., Wentzel, E.A., Arking, D.E., West, K.M., Dang, C.V., Thomas-Tikhonenko, A. and Mendell, J.T. (2008) Widespread microRNA repression by Myc contributes to tumorigenesis. Nat. Genet. 40, 43-50
39. Nanbru, C., Lafon, I., Audigier, S., Gensac, M.C., Vagner, S., Huez, G. and Prats, A.C. (1997) Alternative translation of the proto-oncogene c-myc by an internal ribosome entry site. J. Biol. Chem. 272, 32061-32066
40. Sherrill, K.W., Byrd, M.P., Van Eden, M.E. and Lloyd, R.E. (2004) BCL-2 translation is mediated via internal ribosome entry during cell stress. J. Biol. Chem. 279, 29066-29074
41. Shi, Y., Sharma, A., Wu, H., Lichtenstein, A. and Gera, J. (2005) Cyclin D1 and c-myc internal ribosome entry site (IRES)-dependent translation is regulated by AKT activity and enhanced by rapamycin through a p38 MAPK- and ERK-dependent pathway. J. Biol. Chem. 280, 10964-10973
42. Chappell, S.A., Edelman, G.M. and Mauro, V.P. (2000) A 9-nt segment of a cellular mRNA can function as an internal ribosome entry site (IRES) and when present in linked multiple copies greatly enhances IRES activity. Proc. Natl. Acad. Sci. U.S.A. 97, 1536-1541
43. Cobbold, L.C., Wilson, L.A., Sawicka, K., King, H.A., Kondrashov, A.V., Spriggs, K.A., Bushell, M. and Willis, A.E. (2010) Upregulated c-myc expression in multiple myeloma by internal ribosome entry results from increased interactions with and expression of PTB-1 and YB-1. Oncogene 29, 2884-2891